Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Corvus Pharmaceuticals, Inc. CRVS

Full chart Compare
Set alert

Price alert · CRVS

All alert types
9.73 USD 0.00 (+0.00%)

At closeNov 6, 2026, 9:08 AM EST

9.85 +0.12 +1.19%

Pre-market · Nov 6, 9:08 AM ET

Day range unavailable

6.39 52-week range 26.95
YTD
+26.36%
1 year
+29.22%

Financial health

Altman Z-Score

28.74 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -40.5×
FY 2016: -6.1×FY 2017: -3.8×FY 2018: -2.1×FY 2019: -3.7×FY 2020: -17.8×FY 2021: -2.3×FY 2022: -1.0×FY 2023: -3.1×FY 2024: -5.2×FY 2025: -40.5×
FY 2016 5y median -3.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 9.9×
FY 2016: 1.7×FY 2017: 2.5×FY 2018: 0.9×FY 2019: 2.2×FY 2020: 1.5×FY 2021: 1.0×FY 2022: 0.7×FY 2023: 2.2×FY 2024: 10.0×FY 2025: 9.9×
FY 2016 5y median 2.2× FY 2025
P/FCF -18.4×
FY 2016: -7.3×FY 2017: -4.6×FY 2018: -2.4×FY 2019: -4.3×FY 2020: -3.0×FY 2021: -2.7×FY 2022: -1.4×FY 2023: -3.5×FY 2024: -12.8×FY 2025: -18.4×
FY 2016 5y median -3.5× FY 2025
EV/EBITDA -39.8×
FY 2016: -2.4×FY 2017: -2.2×FY 2018: 0.3×FY 2019: -3.3×FY 2020: -16.9×FY 2021: -1.0×FY 2022: -0.7×FY 2023: -2.7×FY 2024: -5.1×FY 2025: -39.8×
FY 2016 5y median -2.7× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -5.4%
FY 2016: -13.6%FY 2017: -21.9%FY 2018: -40.9%FY 2019: -23.4%FY 2020: -33.2%FY 2021: -36.4%FY 2022: -69.0%FY 2023: -28.4%FY 2024: -7.8%FY 2025: -5.4%
FY 2016 5y median -28.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -25.0%
FY 2016: -27.4%FY 2017: -65.6%FY 2018: -42.5%FY 2019: -65.6%FY 2020: -8.3%FY 2021: -44.5%FY 2022: -73.6%FY 2023: -69.9%FY 2024: -191.3%FY 2025: -25.0%
FY 2016 5y median -69.9% FY 2025
ROIC -69.1%
FY 2016: -27.8%FY 2017: -66.6%FY 2018: -44.6%FY 2019: -65.8%FY 2020: -58.8%FY 2021: -38.3%FY 2022: -55.5%FY 2023: -58.4%FY 2024: -81.8%FY 2025: -69.1%
FY 2016 5y median -58.4% FY 2025
ROA -21.5%
FY 2016: -26.0%FY 2017: -58.7%FY 2018: -39.7%FY 2019: -55.8%FY 2020: -7.0%FY 2021: -39.5%FY 2022: -60.5%FY 2023: -59.3%FY 2024: -90.4%FY 2025: -21.5%
FY 2016 5y median -59.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -56.0%
FY 2016: -168.5%FY 2017: -52.9%FY 2018: 12.9%FY 2019: 0.7%FY 2020: 10.4%FY 2021: 11.7%FY 2022: 15.7%FY 2023: 28.1%FY 2024: -17.7%FY 2025: -56.0%
FY 2016 FY 2025
EPS (diluted) 48.0%
FY 2016: -53.2%FY 2017: -15.3%FY 2018: 37.1%FY 2019: 12.9%FY 2020: 86.6%FY 2021: -415.0%FY 2022: 13.6%FY 2023: 36.8%FY 2024: -81.2%FY 2025: 48.0%
FY 2016 FY 2025
Free Cash Flow -29.7%
FY 2016: -129.9%FY 2017: -54.6%FY 2018: 11.0%FY 2019: 9.7%FY 2020: 6.7%FY 2021: -5.4%FY 2022: 25.7%FY 2023: 12.2%FY 2024: -6.1%FY 2025: -29.7%
FY 2016 FY 2025

Financial Health

Current Ratio 6.2×
FY 2016: 18.4×FY 2017: 9.1×FY 2018: 14.5×FY 2019: 7.8×FY 2020: 3.7×FY 2021: 7.4×FY 2022: 4.1×FY 2023: 4.1×FY 2024: 1.5×FY 2025: 6.2×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 6.2×
FY 2016: 18.5×FY 2017: 9.1×FY 2018: 14.6×FY 2019: 7.8×FY 2020: 3.7×FY 2021: 7.4×FY 2022: 4.1×FY 2023: 4.1×FY 2024: 1.5×FY 2025: 6.2×
FY 2016 5y median 4.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 3.8×FY 2017: 1.6×FY 2018: 2.5×FY 2019: 0.0×FY 2020: 2.6×FY 2021: 1.4×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: -61.5×FY 2017: 0.0×FY 2018: -21.6×FY 2019: -22.4×FY 2020: -81.0×FY 2021: -2575×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31